The Pharmaceutical Research and Manufacturers of America and its member companies join the European Federation of Pharmaceutical Industries and Associations in raising significant concerns with a number of the proposed revisions to Directive 2001/83/EC and Regulation EC 726/2004.
PRM
The Pharmaceutical Research and Manufacturers of America (PhRMA)
Industry association · United States
3
positions filed
in the 583 files tracked
3
legislative files
of 583 tracked
3
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track The in PolicySpeak: request access →
Work at The Pharmaceutical Research and Manufacturers of America (PhRMA)? so we know who speaks for it.
Their record over time
The Pharmaceutical Research and Manufacturers of America (PhRMA) filed 3 positions between 31 Jul 2023 and 8 Nov 2023, across 3 of the 583 legislative files tracked here, attaching a full position paper 3 times.
What they argued
PhRMA has serious concerns with the ECs proposed regulation to establish a pan-EU compulsory licensing (CL) mechanism for crisis management. Although most respondents during the consultation process supported a coordinating role only for the EU institutions related to CLs, the proposed regulation goes significantly further.
PhRMA joins EFPIA in raising significant concerns with the European Commissions (ECs) proposal to establish a new mechanism for parties to oppose the grant of SPCs. While PhRMA supports the general intent of the proposed recast of the SPC Regulation to establish a centralized process for seeking SPCs in the EU without altering the substance of that protection, the proposed procedure includes redundant and…
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put The Pharmaceutical Research and Manufacturers of America (PhRMA) next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 43.
Is this your organization?
Everything on this page comes from The Pharmaceutical Research and Manufacturers of America (PhRMA)’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.